
Feb 13, 2022
The leaders of six opposition parties in Turkey have met for the first time to strategize about the future of the country’s governing system
ISTANBUL (AP) — The leaders of six opposition parties in Turkey have met to strategize about the future of the country’s governing system — a move that aims to unseat the country's longtime ruler.
In a statement following the dinner Saturday night, the party leaders said Turkey was experiencing “the deepest political and economic crisis” of its history and blamed it on the executive presidential system. They said their joint goal was to transform Turkey’s governance to a “strengthened parliamentary system.”
They did not mention President Recep Tayyip Erdogan by name, but their clear aim is to find a way to work together to unseat him.
After more than 11 years as Turkey's prime minister, Erdogan was elected president in 2014. At the time, the position was primarily ceremonial. But in 2017, Turkish voters approved an executive presidential system, greatly expanding Erdogan's powers at the expense of those of the prime minister and parliament. Erdogan was re-elected the following year. Critics call the system “one-man rule.”
The leaders at the dinner were Kemal Kilicdaroglu, the head of the main opposition Republican People’s Party; Meral Aksener from the nationalist Good Party; Temel Karamollaoglu from the conservative Felicity Party; Gultekin Uysal from the Democrat Party; Democracy and Progress Party’s Ali Babacan; and Future Party’s Ahmet Davutoglu. They had previously conducted bilateral meetings but Saturday's meeting was their first all together. They are expected to release details of their agreement on Feb. 28.
Davutoglu and Babacan were co-founders of Erdogan’s ruling party and served in top positions but broke away to form their own parties in criticism of Erdogan’s policies.
The second-largest opposition party, the pro-Kurdish Peoples’ Democratic Party, was not at the meeting. The government has attacked that party and many of its members, including its former leaders, have been imprisoned over alleged links to outlawed Kurdish militants. Erdogan has also accused the Republican People’s Party of siding with “terrorists,” claims the party denies.
The next parliamentary and presidential elections in Turkey are scheduled for June 2023.
Despite strong revenues and profits, the streaming service cut 1,000 jobs and jettisoned its chief content officer. Drops in the stock price and viewer engagement are to blame.
Commercials with Sydney Sweeney promoting a gambling platform and Megan Fox endorsing male enhancement have rankled fans, and even athletes. Who is in charge?
In the contrarian logic of investing, rising interest rates have made bonds much more attractive, our columnist says.
Higher interest rates are inflating borrowing costs as the Trump administration spends on the Iran war and tariff refunds.
The potential downgrade by MSCI, an influential index provider, adds to a deepening crisis of investor confidence in the economic policies of President Prabowo Subianto.
The Federal Reserve chairman stuck to his pledge to avoid providing guidance about the path forward for interest rates, but did nothing to convey an urgency to raise them later this month.
Tesla CEO Elon Musk showcased the vehicle at a facility owned by his SpaceX company, which helped develop the model.
Kevin Warsh, the central bank’s chairman, suggested he wouldn’t push to raise borrowing rates this month. But persistent inflation may force the Fed’s hand.
Senior banking executives have told the BBC they expect to be "on the menu" in the chancellor's Budget tax later this month.
The booking giant is accused of breaking federal antitrust laws and forcing millions of customers to overspend on stays by as much as 30 percent.
Elon Musk’s company and other automakers, like Jaguar and Bentley, are trying to sell very expensive electric cars to people who usually prefer gasoline-fueled luxury and performance.
President Trump has been promoting his efforts to reduce drug prices, but many Americans have not seen relief from rising costs for prescriptions and insurance premiums.